Sign In
9 May 2018 13:14
FOR IMMEDIATE RELEASE 9 May 2018
Cello Health plc
Result of AGM
At the Annual General Meeting of Cello Health plc (AIM:CLL) held today, all the resolutions put to shareholders were duly passed.
Enquiries:
Cello Health plc | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Group Finance Director
| |
Cenkos Securities plc | |
Mark Connelly/Harry Hargreaves | 020 7397 8900 |
Buchanan Mark Court | 020 7466 5000 |
Jamie Hooper | |
Sophie Wills | |
About Cello Health plc
We are a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. We currently service 24 of the top 25 pharmaceutical clients globally as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.
We enable clients to differentiate their propositions and drive brand success in ever more complex global markets. We deliver our services through nearly 1,000 highly skilled professionals utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York, Philadelphia, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit: https://cellohealthplc.com/
Follow the stocks
